Understanding Peptide MOQs and Unit Economics

moq is not a number a supplier invented to be difficult. it exists because a big share of the cost of a production run is fixed: the synthesis batch has a minimum viable size, the fill line has to be cleaned and changed over, the label needs plates, the carton needs a die. spread those over 200 units and the per-unit cost is brutal. spread them over 5,000 and it disappears. understanding that is what lets you negotiate intelligently instead of just asking for a lower number.

business and operations only — not legal, medical or investment advice. run your own numbers and have your attorney review anything touching labeling, claims or imports.

where MOQs come from

• —synthesis scale. solid phase synthesis runs at batch sizes. a partial batch still consumes resin, reagents and column time.
• —fill line changeover. cleaning, setup, validation and line clearance take hours whether you fill 300 vials or 30,000.
• —print setup. label plates and carton dies are one-time costs per artwork; short runs pay them across few units.
• —QC batch testing. a lot gets the same test panel regardless of size, so testing cost per unit falls with scale.
• —administrative overhead. purchase order, documentation, quality release and shipping paperwork cost roughly the same per order.

note which of these are per-lot versus per-unit. that split is the entire lever in a moq negotiation. anything per-lot, you can sometimes pay directly as a setup fee to unlock a smaller run.

the landed cost model

build this in a spreadsheet before any conversation about price. per-unit costs first.

• —peptide api or finished unit cost at your actual order quantity
• —fill, lyophilization and capping if quoted separately
• —vial, stopper, flip-off seal
• —label and carton material cost per unit
• —inbound freight and duty per unit
• —3PL receiving and per-unit storage for expected holding period
• —pick, pack and packout materials including cold chain

then one-time costs for the run: label plates, carton die, artwork and legal review, line changeover or setup fee, per-lot QC testing, your independent confirmatory testing, and customs brokerage.

amortize against sellable units, not ordered units

this is the step that separates a real model from a naive one. divide one-time costs by the units you will actually sell before expiry, after subtracting expected shrink — breakage, failed QC, samples pulled for testing, and short-dated stock you will end up discounting or writing off. two to five percent shrink is realistic. if you order 3,000 units and honestly expect to sell 2,650 before dating, amortize across 2,650.

a worked comparison

supplier A quotes $14 a unit at a 500 unit moq with a $2,400 setup fee. supplier B quotes $9 a unit at a 3,000 unit moq with no setup fee. naive comparison says B wins by $5 a unit. run it properly.

1. 1.supplier A: 500 units × $14 = $7,000, plus $2,400 setup, plus roughly $900 in plates, dies and testing, plus $600 freight. total $10,900 across ~475 sellable units, so about $22.95 landed before fulfillment.
2. 2.supplier B: 3,000 units × $9 = $27,000, plus $900 setup-equivalent costs, plus $1,600 freight and brokerage. total $29,500 across ~2,850 sellable units, so about $10.35 landed before fulfillment.
3. 3.B is genuinely cheaper per unit — but it requires $29,500 in cash versus $10,900, and at 40 units a day it is 71 days of inventory versus 12 days.
4. 4.now check expiry: if the lot dates in 14 months and you will sell through in three, fine. if velocity is 8 units a day instead of 40, that lot is a year of inventory and part of it will expire.
5. 5.and check opportunity cost: the extra $18,600 spent on ads at even a 2.5 roas returns more than the $12.60 per unit you saved on 2,850 units — but only if you can actually deploy it profitably.

the answer depends on your velocity and your cash position, which is exactly the point. there is no universally right moq, only the right moq for your current volume.

when acquisition performs like that, cash deployed into ads compounds faster than cash deployed into a price break. that flips the usual instinct: at scale you often want smaller, more frequent orders and more capital in the market, not a warehouse full of discounted units.

the cash cycle question

gross margin tells you whether a unit is profitable. cash cycle tells you whether you can survive selling it.

1. 1.you wire the supplier — often 50% deposit up front, balance before shipment. cash out on day zero.
2. 2.production runs, 6-12 weeks. cash is gone, nothing to sell.
3. 3.freight and customs, 1-4 weeks.
4. 4.receiving, quarantine and testing, 1-2 weeks. product is in the building but not sellable.
5. 5.you sell through over the following weeks or months, with payment processor holds and reserves delaying some receipts.

from wire to fully recovered cash can easily be five or six months on a large first order. that number, not gross margin, determines how big an order you can responsibly place. a business with a 78% gross margin can still die by putting six months of cash into a fridge.

negotiating a smaller first run

• —offer to pay the setup as an explicit fee rather than asking for the moq to be waived. this makes the supplier whole on the per-lot costs and is usually the fastest yes.
• —ask to piggyback on an existing production run of the same peptide, taking a partial lot. many fill-finish partners can do this.
• —commit to a volume schedule — a smaller first order with a contractual commitment to a larger second within a defined window.
• —accept their stock vial, stopper and carton formats for run one and customize on run two. component customization drives a lot of moq.
• —start with a simpler label — fewer colors, no foil or special finish — to reduce plate cost on the first run.
• —pay faster. shorter payment terms are worth real money to a manufacturer and are often tradeable against quantity.

what does not work is asking for a lower moq at the same unit price with no other concession. you are asking them to lose money on your order to earn your business, and the ones who say yes to that are usually the ones you should not be buying from.

pricing backward from landed cost

once you have landed cost, price is not a guess.

• —target landed cost at or under 20-25% of retail on your core sku. that is the range where paid acquisition works in this category.
• —reserve for refunds and chargebacks. in this space, plan for it explicitly rather than hoping.
• —reserve for shipping subsidy — free shipping over a threshold costs you real money once packout is included.
• —leave room for a cac your channel can actually deliver, plus payment processing fees which run higher than standard rates in this category.
• —then check contribution margin after all of that. if it is thin, the fix is upstream in sourcing, not downstream in ad optimization.

you do not optimize your way out of a bad landed cost. the ad account can only spend what the unit economics allow.

reorder economics

the second order is a different deal from the first and you should renegotiate it as one. plates and dies are paid for, artwork is approved, the process is validated, and you now have demonstrated volume. that is leverage. ask for a better unit price, tighter lead time commitments, coa included, and ideally some form of consignment or extended terms. suppliers who want a long relationship will move on at least one of those.